Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
Pediatric Studies Characteristics - Detail
FDA Home
Pediatrics
Pediatric Studies Characteristics
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Approval Date:
01/29/2010
Trade Name:
Lamictal XR
Generic or Proper Name (*):
lamotrigine
Indications Studied:
Adjunctive therapy for Primary Generalized Tonic-Clonic seizures
Therapeutic Category:
Anticonvulsant
Ages Studied:
13 years and older
Study #:
1
Study Type:
Efficacy/Safety/Pharmacokinetic
Study Design:
Single-Blind/Parallel Group
No Patients:
19
No Centers:
51
No Countries:
10
BPCA(B), PREA(P):
P
-
-